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Abstract
Background: Interscalene nerve block and liposomal bupivacaine have been found to provide adequate pain control
following shoulder arthroplasty. We hypothesized that local infiltration of a periarticular cocktail would provide equivalent pain control compared to interscalene nerve block and liposomal bupivacaine.
Methods: Eighty-seven patients undergoing primary shoulder arthroplasty were treated with local infiltration of a
periarticular cocktail (200 mg of 0.5% ropivacaine, 1 mg epinephrine, and 30 mg ketorolac), local infiltration of liposomal
bupivacaine, or preoperative interscalene nerve block. The outcomes of the study were postoperative visual analog scale
scores, opioid consumption, length of stay, and complications.
Results: A total of 30 patients receiving local infiltration of a periarticular cocktail, 26 receiving liposomal bupivacaine,
and 31 receiving interscalene nerve block were included in the study. Patients who received local infiltration of a
periarticular cocktail had a significantly lower mean visual analog scale when compared to interscalene nerve block
and liposomal bupivacaine on postoperative day 0 (2.5 versus 4.0 versus 4.8, P ¼ 0.001 and P < 0.001). Pain scores
between postoperative day 0–3 were lower in patients who received local infiltration of a periarticular cocktail, but
not significantly. Patients who received local infiltration of a periarticular cocktail required significantly less opioids than
the interscalene nerve block group on postoperative day 0 (P < 0.001).
Discussion: A decrease in early postoperative pain and opioid consumption was found with local infiltration of a
periarticular cocktail when compared with interscalene nerve block and liposomal bupivacaine after shoulder
arthroplasty.
Level of evidence: Level II
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Introduction
Pain control following shoulder arthroplasty has been
shown to inﬂuence patient outcomes, patient satisfaction, and healthcare costs.1,2 More recently there have
been increased eﬀorts to ﬁnd multimodal regimens
that control pain and decrease the use of opioids.
Both regional and local anesthesia have been used in
shoulder arthroplasty and have demonstrated adequate
pain control.3,4
Interscalene nerve blocks (INBs) are a reliable
method of regional anesthesia for shoulder arthroplasty

and have been shown to improve postoperative pain
scores, patient satisfaction, and decrease length of
stay.5,6 However, INB has been associated with postoperative
complications
including
respiratory
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compromise and neurological palsies, as well as
rebound pain leading to patient discomfort.5,7 The
beneﬁts of regional anesthesia must be weighed against
the potential risk of complications. Another option for
pain control that has been shown to be highly eﬀective in
total knee and hip arthroplasty is local inﬁltration
analgesia. This form of anesthesia involves inﬁltration
of the periarticular tissues intraoperatively with a
‘‘moving needle’’ technique.8 This can be performed
using a single anesthetic agent or a cocktail of medications including ropivacaine, ketorolac, morphine, and
epinephrine. This technique avoids the risks of pneumothorax and brachial plexus injury that are seen with INB.
Previous studies have found that use of local inﬁltration analgesia with liposomal extended-release bupivacaine (Exparel, Pacria Pharmaceuticals, Inc.,
Parsippany, NJ) in shoulder arthroplasty is comparable
to INB in terms of pain scores, morphine consumption,
and length of hospital stay.3,9 However, other studies
have shown that local inﬁltration analgesia with a
simple cocktail of ropivacaine, epinephrine, and ketorolac in total knee arthroplasty is also associated with
lower pain scores and total opiate use.10 No previous
studies have compared local inﬁltration analgesia with
liposomal bupivacaine (LB), local inﬁltration cocktail
(LIC), and INB for pain control following shoulder
arthroplasty. The purpose of this study was to perform
a prospective cohort study comparing three common
methods for pain control in patients undergoing shoulder arthroplasty. Our hypothesis was that LIC would
provide equivalent pain control compared to INB and
LB at decreased cost.

Materials and methods
We performed a non-industry sponsored, prospective
cohort study. Approval was obtained from the Henry
Ford Health System Institutional Review Board prior
to initiation of the study. From October 2014 through
March 2018, 87 adult patients undergoing either primary anatomic or reverse total shoulder arthroplasty
were consented for participation. Surgery was performed by one of three fellowship-trained orthopaedic
surgeons using a deltopectoral approach. All surgeries
were performed under general anesthesia in the beach
chair position. Patients were excluded if their medical
history revealed known allergies or intolerance to dexamethasone, bupivacaine, ropivacaine, ketorolac, epinephrine, or opioid medications; history of substantial
alcohol or drug abuse; and history of current pregnancy. According to institutional protocol at the time
of the surgery, patients were consecutively enrolled into
the three groups. Of eligible patients, 31 patients
received INB, 26 patients received LB, and 30 patients
received LIC.

INB was performed 1 h prior to surgery under ultrasound guidance by a certiﬁed anesthesiologist experienced in the technique. A single dose of 40 ml of 0.5%
ropivacaine was injected into the nerve sheath of the brachial plexus utilizing a 22-gauge needle of 80 mm length.
The LIC contained a mixture of 200 mg of 0.5% ropivacaine, 1 mg epinephrine, and 30 mg ketorolac. The LB
injection contained 20 ml of LB (266 mg) diluted in
20 ml of sterile saline. Both injections were inﬁltrated
locally using a standardized protocol at the completion
of component implantation and before incision closure.
A 60 ml syringe with a 1 in., 18-gauge needle was used to
administer the injection. Five milliliters were injected into
the periosteum, 10 ml into the deltoid administered in
2 ml increments spread over the deltoid muscle anteriorly,
10 ml into the pectoralis major muscle (administered in
2 ml increments), and the ﬁnal 15 ml were injected evenly
into the subcutaneous tissue along the incision. Patients
were then placed on a standardized postoperative pain
regimen consisting of acetaminophen 650 mg every 8 h,
oxycodone 5 mg every 4 h as needed for pain levels less
than 5, oxycodone 10 mg every 4 h as needed for pain
levels greater than 5, and morphine 2 mg every 4 h as
needed for severe breakthrough pain during the hospital
stay. Patient outcomes were self-recorded using a visual
analog scale (VAS) every 4 h for 96 h in a pain diary.
Opioid requirements were obtained from the medical
record and pain diary after discharge. Opioid doses
were converted to intravenous morphine equivalents
prior to data analysis. This was performed using standardized morphine equivalent conversion factors according
to the Centers for Disease Control.11 Length of hospital
stay was also obtained from the medical record and calculated from the time of surgery.

Statistical analysis
The primary outcome of interest in this study was average VAS score diﬀerence of 13 mm between the INB,
LB, and LIC groups. This was based on previous literature demonstrating that a diﬀerence of 13 mm on VAS
between two groups represents a clinically signiﬁcant
change.12 A power analysis was performed to assess
the hypothesis that a signiﬁcant diﬀerence in average
pain of 13 mm on the VAS would not be found between
the three groups. With power of 80% (b level ¼ 0.80,
a level ¼ 0.05), a sample size of 25 patients per group
was obtained. Secondary outcomes collected included
average opioid use and postoperative length of stay.
Demographics and the outcomes of interest were compared between each treatment type at 4 h intervals within
the ﬁrst 24 h, and at each postoperative day (POD).
All results were ﬁrst analyzed using analysis of variance. Then, if signiﬁcant diﬀerences between groups
were detected, a post hoc of least signiﬁcant diﬀerence
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was performed. In each table, results of ANOVA are
shown in one column and, if signiﬁcance was found,
post-hoc tests were performed, and the results shown
in the table or legend. If signiﬁcant diﬀerences were
not found, averages were still reported absent p-values.
A general linear model univariate with post hoc of least
signiﬁcant diﬀerence, and Pearson’s chi-square test were
also used. For all analyses, P < .05 was considered
statistically signiﬁcant. Analyses were performed using
SPSS software (Version 25, IBM, Armonk, NY).

Results
A total of 97 patients were evaluated for inclusion in
the study. Ten patients declined participation. A total
of 87 total patients were included and analyzed. Thirty
patients received local inﬁltration analgesia with LIC,
31 patients received INB, and 26 patients received local
inﬁltration analgesia with LB. Diﬀerences in demographic variables between the groups are presented in
Table 1. In the LIC group, nine patients (31%) were
using opioid pain medication, most commonly hydrocodone, for at least three months prior to their surgery
compared to zero patients in the INB or LB groups.
Comparisons of postoperative VAS are shown in
Tables 2 and 3. Patients in the LIC group had signiﬁcantly
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reduced pain when compared to INB at 9–12 h and again
at 17 h postoperative (3.04 versus 4.90, P ¼ .003) through
the remainder of POD 1. The LIC group had lower pain
scores overall for the ﬁrst POD (2.46 versus 3.95,
P < .001). When compared to LB, LIC demonstrated signiﬁcantly reduced pain starting immediately postoperatively (2.24 versus 5.28, P < .001) and lasting through
the entire ﬁrst POD. After POD 1, LIC had similar pain
scores when compared to INB and LB.
The postoperative opioid usage per group is reported
in Tables 4 and 5. Patients in the LIC group had signiﬁcantly reduced average opioid consumption when
compared to INB beginning at 5 h postoperative (1.12
versus 3.71, P < .001) and overall for the ﬁrst 24 h postoperative (10.84 versus 21.42, P < .001). Morphine
usage was also lower in the LIC group compared to
LB at 5–8 h postoperative (1.12 versus 2.58, P ¼ .046).
Morphine usage was signiﬁcantly higher on POD 3 in
the LIC group compared to both LB and INB (7.54
versus 2.90 versus 2.18, P ¼ .033 and .011, respectively).
While the average day of discharge was POD 2,
length of hospital stay was signiﬁcantly shorter for
the LIC group compared to both the INB and LB
groups, 1.07 versus 1.5 versus 1.5 days (P < .001),
respectively. One patient in the INB group sustained
a phrenic nerve palsy requiring readmission for

Table 1. Patient demographics.
LIC
Number of patients

INB

ANOVA
P-value

LB

30 (34.5%)

31 (35.6%)

26 (29.9%)

Males

15 (17.2%)

16 (18.4%)

12 (13.8%)

0.916

Females

15 (17.2%)

15 (17.2%)

14 (16.1%)

0.916

Mean age (SD), years

73.5 (7.8)

67.3 (12.9)

69.4 (8.1)

.054

Mean BMI, kg/m2 (SD)

28.6 (7.0)

29.8 (5.3)

32.3 (6.5)

.090

Estimated blood loss, ml (SD)

67.7 (34.7)

128.1 (149.3)

86.54 (36.2)

0.041*

106.5 (40.0)

134.3 (27.7)

134.31 (35.9)

0.003*

Operative time, min (SD)
Surgery
TSA

2 (2.3%)

15 (17.2%)

18 (20.7%)

<0.001

RTSA

28 (33.2%)

16 (18.4%)

8 (9.2%)

<0.001

ANOVA: analysis of variance; BMI: body mass index; INB: interscalene nerve block; LB: liposomal bupivacaine; LIC: local
infiltration cocktail; RTSA: reverse total shoulder arthroplasty; TSA: total shoulder arthroplasty.
Note that percentages are calculated with respect to the group rather than the entire cohort.
*Post-hoc test results: Average blood loss is higher in INB versus LIC (p ¼ 0.014). Average surgical time is lower in the
LIC group compared to both the INB (p ¼ 0.002) and LB (p ¼ 0.004) groups. There were significantly more RTSAs in the
LIC group compared to both the INB and LB groups (p < 0.001 for both). There were significantly less TSAs in the LIC
group compared to both the INB and LB groups (p < 0.001 for both). Bold values are statistically significant.
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Table 2. Pain scores by hours (mean  SD).
Hours after
surgery

P-value LIC
versus INB

LB

P-value LIC
versus LB

ANOVA
P-value

LIC

INB

0–4

2.24  1.55

2.59  3.05

0.572

5.28  2.23

0.001

<0.001

5–8

2.80  2.43

2.93  3.12

0.856

4.93  2.32

0.006

0.006

9–12

2.60  2.21

3.78  3.05

0.045

5.09  2.54

<0.001

0.003

13–16

2.60  2.13

3.97  3.39

0.076

4.38  2.45

0.030

0.042

17–20

3.04  2.11

4.90  2.23

0.003

4.67  2.43

0.014

0.004

21–24

2.46  1.48

5.38  2.13

<0.001

4.54  2.48

<0.001

<0.001

ANOVA: analysis of variance; INB: interscalene nerve block; LB: liposomal bupivacaine; LIC: local infiltration cocktail.

Table 3. Pain scores by days (mean  SD).
Postoperative
day

LIC

INB

P-value LIC
versus INB

LB

P-value LIC
versus LB

ANOVA
P-value

Day 0

2.46  1.47

3.95  1.75

0.001

4.80  1.83

<0.001

<0.001

Day 1

3.25  1.82

4.30  2.16

4.14  2.16

0.11

Day 2

3.29  1.98

3.63  1.65

4.34  2.47

0.15

Day 3

2.83  1.63

4.30  2.16

0.053

4.14  2.01

0.067

0.008

ANOVA: analysis of variance; INB: interscalene nerve block; LB: liposomal bupivacaine; LIC: local infiltration cocktail.

Table 4. Morphine equivalent use by hours (mean  SD).
Hours after
surgery

P-value LIC
versus INB

LB

P-value LIC
versus LB

ANOVA
P-value

LIC

INB

0–4

4.29  2.93

3.23  3.02

5–8

1.12  2.11

3.71  2.95

<0.001

2.58  2.90

0.046

0.001

9–12

1.15  2.01

3.61  2.61

<0.001

2.43  2.85

0.064

0.001

13–16

1.63  2.16

4.65  3.47

<0.001

2.45  2.38

0.302

<0.001

17–20

1.61  2.44

3.39  3.96

0.026

2.70  2.77

0.191

0.009

21–24

1.05  1.91

2.84  4.46

0.036

2.10  2.69

0.239

0.01

2.78  2.52

0.13

ANOVA: analysis of variance; INB: interscalene nerve block; LB: liposomal bupivacaine; LIC: local infiltration cocktail.

respiratory compromise. There were no complications
in the LB or LIC groups.

Discussion
INBs and local inﬁltration analgesia with LB have been
used with success for perioperative pain control in

shoulder arthroplasty. Our study found that local inﬁltration with a simple cocktail is associated with signiﬁcantly reduced pain scores and opiate consumption on
POD 0 when compared to INB and LB. Following POD
0, these diﬀerences were not statistically signiﬁcant. LIC
oﬀers another cost-eﬀective alternative that can be used
to manage pain control following the procedure.
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Table 5. Morphine equivalent use by days (mean  SD).
Postoperative
day

LIC

INB

P-value LIC
versus INB

LB

P-value LIC
versus LB

ANOVA
P-value

Day 0

10.84  7.85

21.42  11.28

<0.001

15.04  9.09

0.109

<0.001

Day 1

11.49  10.74

9.11  11.43

8.98  9.53

0.599

Day 2

9.19  9.58

5.21  10.79

12.83  17.00

0.081

Day 3

7.54  10.41

2.18  6.11

0.011

2.90  4.13

0.033

0.014

ANOVA: analysis of variance; INB: interscalene nerve block; LB: liposomal bupivacaine; LIC: local infiltration cocktail.

These analgesic methods have varying mechanisms
of action to help control pain. Anesthetics such as ropivacaine and bupivacaine work by inhibiting the transmission of action potentials in sensory nerve ﬁbers.13
When used as a perineural inﬁltration, such as with
INB, this results in a widespread anesthetic eﬀect that
can be used both intra- and postoperatively for pain
control.4 When used locally such as with LIC or LB,
the inhibition of local nociceptors limits transmission of
pain signals. A depot formulation such as LB helps to
slow systemic absorption and prolong the local
eﬀects.14 Adjuvants such as epinephrine can be used
to constrict the local vasculature, delaying absorption,
and prolonging the eﬀects of the inﬁltration.13
Ketorolac is included as a non-steroidal anti-inﬂammatory medication to control pain caused by the local
inﬂammatory response to surgical trauma. When ketorolac is used in a LIC, it has been shown to provide
superior pain control compared to cocktails that do
not include ketorolac.15 Therefore, the LIC is a multimodal therapy, which acts to control varying types of
pain with multiple adjuvant medications at the site of
surgery. Studies have shown that absorption of locally
injected medications, including ropivacaine, bupivacaine, and ketorolac, does not lead to systemically
toxic levels.14,15
LICs with the same medications used in this study
have been well studied in hip and knee arthroplasty.
Most of these authors used the same combination of
medications as were used in this study.8,16 Other
authors also add morphine to their cocktail, but all
have achieved similar success.17,18 A randomized controlled trial of total knee patients showed improved
patient satisfaction and decreased pain scores in the
ﬁrst 24 h postoperatively with use of a multimodal periarticular cocktail.18 Bagsby et al.17 compared LB to a
traditional LIC in total knee patients and found
improved pain control with the LIC throughout the
hospital stay. Previous studies in shoulder arthroplasty
patients have compared INB and LB and found no
signiﬁcant diﬀerence in pain control.3,9 Our results are
consistent with these studies, showing comparable

results between the methods of analgesia. In comparison to INB, LIC was associated with decreased VAS
scores on POD 0. VAS was similar between the two
groups from 0 to 16 h postoperatively; however, after
16 h the LIC group demonstrated lower pain scores.
This may be related to the duration of action of the
INB, which is on average 18 h as reported in Goon
et al.19 After the nerve block wears oﬀ, patients have
been found to have an increase in rebound pain compared to a more consistent pain proﬁle in patients who
do not receive a block. From Table 2, it appears that
the block started to wear oﬀ at 9 h postoperatively for
this study group and patients likely experienced
rebound pain at approximately 21–24 h. The LIC
group also did not demonstrate a dramatic increase in
pain scores over the course of POD 0, suggesting more
even pain control. When compared to LB, LIC was
associated with signiﬁcantly lower VAS at all time
points on POD 0. These results demonstrate better
pain control using a multi-ingredient cocktail for local
injection rather than using a single long-acting agent.
Physicians must determine if there is an additional
beneﬁt of using a more expensive long-acting agent
when a mix of cheaper agents achieves improved pain
control.
When evaluating morphine requirements in patients
undergoing total knee arthroplasty, studies have shown
decreased morphine usage for the ﬁrst 48 h after surgery
with use of LIC.16 However, comparisons of LIC with
LB in total hip and knee arthroplasty show a larger
decrease in opiate usage with LB.20,21 Studies comparing INB with LB in total shoulder arthroplasty show
similar opiate usage.3,9 One study showed lower opiate
consumption with INB compared to LB; however, they
used an indwelling catheter rather than a single injection.22 In this study, results were consistent with the
total shoulder literature. LIC was associated with
decreased opiate use when compared to INB on POD
0. There was not a signiﬁcant decrease in morphine
equivalent usage when comparing LIC and LB. This
is likely to be related to the formulation of LB, which
is designed to release anesthetic slowly over the course
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of a number of days.14 Opiate use was signiﬁcantly
increased in the LIC group on POD 3. This may be
related to the prevalence of preoperative opiate usage
in this group as 31.0% (nine patients) were using opioid
medications for at least three months prior to their surgery, and therefore, did not demonstrate the equivalent
decrease in opiate usage on POD 3 as in the other two
groups. There were no patients using preoperative opiates in the LB and INB groups. Despite this, the LIC
group still had adequate pain control compared to the
other groups which indicates that this may be a good
option for analgesia in that population.
Complications of INB have been evaluated in
numerous studies.7,23,24 In a prospective study of 218
patients, Weber and Jain24 found a failure rate of 13%
and abnormal neurologic responses in 5% of patients at
24 h. Other studies have reported rates of acute complications as high as 16%, with persistent neurological
complications in 4.4%.23 Of note, bupivacaine is associated with higher risks of central nervous system and
cardiac toxicity when compared to ropivacaine when
administered intravenously.25 These risks are lower
with the liposomal formulation of bupivacaine and
with local injection, but are important factors to consider.24,26 Our study is consistent with these results with
only one patient sustaining a phrenic nerve palsy after
INB and no complications following LB or LIC.
However, in patients with medical comorbidities who
may be placed at higher risk of complications with general anesthesia, the combination of regional anesthesia
with INB and sedation is the more reasonable option.
In terms of healthcare costs, length of stay was signiﬁcantly shorter in the LIC group. This has potential
implications for overall system-wide cost savings as this
can lead to decreased costs for the patient and increased
availability of beds to support higher surgical volumes.
With increasing emphasis on outpatient surgery, LIC
can provide reliable pain control for patients being discharged immediately following shoulder arthroplasty.
Additionally, there is a large diﬀerence in cost for
each of these methods of analgesia. The average wholesale cost of LB in our region is $315 and the physician
fee for INB based on Current Procedural Terminology
code 64415 is $1583. In comparison, the total wholesale
cost of the LIC at our institution is $24.68, making it a
highly cost-eﬀective alternative to INB and LB.
There are several limitations to our study. The patients
in the LIC group underwent a higher proportion of
reverse compared to anatomic shoulder arthroplasty
and included chronic opiate users, which may have
been confounding factors. The LB and INB groups did
not include chronic opiate users. However, it is encouraging that these chronic pain patients still demonstrated
good pain control. Additionally, recent research has
shown that postoperative pain is equivalent between

TSA and RTSA.27 The study participants were not
blinded to their intervention due to the invasive nature
of the INB. Blinding of the surgeon was not thought to be
necessary as the surgeons were not involved in data collection. However, residents or mid-level providers who
were also not blinded made the decision to discharge
patients based on recommendations from physical and
occupational therapy. Therefore, we do not believe that
the decision to not blind surgeons inﬂuenced our length
of stay measurements. Another limitation is the use of
VAS, which is a subjective measure of pain level and
can limit the patient’s ability to detect subtle changes in
pain and these diﬀerences may not be clinically signiﬁcant.28 Finally, patient compliance, deﬁned as the completeness with which the patient recorded opiate intake
and pain scores, was a limitation. Compliance with pain
diaries was over 80% on POD 0–1 in all groups, but
decreased to 40–50% on POD 2–3.

Conclusion
A decrease in early postoperative pain and opioid
consumption was found with LIC when compared
with INB and LB after shoulder arthroplasty. These
ﬁndings suggest that LIC provides similar pain relief
and opioid requirements at a decreased cost compared
to INB or LB.
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